Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) EBT Margin (2017 - 2019)

Historic EBT Margin for Iterum Therapeutics (ITRM) over the last 3 years, with Q1 2019 value amounting to 55259.46%.

  • Iterum Therapeutics' EBT Margin fell 489468900.0% to 55259.46% in Q1 2019 from the same period last year, while for Dec 2019 it was 278837.84%, marking a year-over-year decrease of 2700250600.0%. This contributed to the annual value of 752.16% for FY2024, which is 5018400.0% down from last year.
  • Per Iterum Therapeutics' latest filing, its EBT Margin stood at 55259.46% for Q1 2019, which was down 489468900.0% from 10063.18% recorded in Q4 2018.
  • Iterum Therapeutics' EBT Margin's 5-year high stood at 2597.99% during Q4 2017, with a 5-year trough of 55259.46% in Q1 2019.
  • Its 3-year average for EBT Margin is 13936.31%, with a median of 8475.14% in 2018.
  • As far as peak fluctuations go, Iterum Therapeutics' EBT Margin tumbled by -46785600bps in 2018, and later plummeted by -489468900bps in 2019.
  • Over the past 3 years, Iterum Therapeutics' EBT Margin (Quarter) stood at 2597.99% in 2017, then crashed by -287bps to 10063.18% in 2018, then plummeted by -449bps to 55259.46% in 2019.
  • Its EBT Margin stands at 55259.46% for Q1 2019, versus 10063.18% for Q4 2018 and 9762.2% for Q3 2018.